Elanco Animal Health Inc (ELAN)
13.15
-0.01
(-0.08%)
USD |
NYSE |
May 01, 16:00
13.15
0.00 (0.00%)
After-Hours: 17:52
Elanco Animal Health Revenue (TTM): 4.417B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.417B |
| September 30, 2023 | 4.367B |
| June 30, 2023 | 4.325B |
| March 31, 2023 | 4.443B |
| December 31, 2022 | 4.412B |
| September 30, 2022 | 4.539B |
| June 30, 2022 | 4.644B |
| March 31, 2022 | 4.748B |
| December 31, 2021 | 4.764B |
| September 30, 2021 | 4.789B |
| June 30, 2021 | 4.548B |
| March 31, 2021 | 3.855B |
| Date | Value |
|---|---|
| December 31, 2020 | 3.271B |
| September 30, 2020 | 2.921B |
| June 30, 2020 | 2.802B |
| March 31, 2020 | 2.998B |
| December 31, 2019 | 3.071B |
| September 30, 2019 | 3.083B |
| June 30, 2019 | 3.073B |
| March 31, 2019 | 3.062B |
| December 31, 2018 | 3.067B |
| September 30, 2018 | 3.022B |
| June 30, 2018 | 2.958B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.802B
Minimum
Jun 2020
4.789B
Maximum
Sep 2021
3.951B
Average
4.367B
Median
Sep 2023
Revenue (TTM) Benchmarks
| Merck & Co Inc | 61.40B |
| Catalent Inc | 4.098B |
| NanoString Technologies Inc | 162.47M |
| Cytokinetics Inc | 7.53M |
| Geron Corp | 0.237M |